home > drugs a-z list > thyrel trh (protirelin) drug center > thyrel trh (protirelin) drug - clinical pharmacology

Pharmacologically, Thyrel TRH (protirelin) increases the release of the thyroid stimulating hormone (TSH) from the anterior pituitary. Prolactin release is also increased. It has recently been observed that approximately 65% of acromegalic patients tested respond with a rise in circulating growth hormone levels; the clinical significance is as yet not clear. Following intravenous administration, the mean plasma half-life of protirelin in normal subjects is approximately five minutes. TSH levels rise rapidly and reach a peak at 20 to 30 minutes. The decline in TSH levels takes place more slowly, approaching baseline levels after approximately three hours.

Last reviewed on RxList: 1/18/2005
This monograph has been modified to include the generic and brand name in many instances.